Predictive Value of MHR and NLR for Ulcerative Colitis Disease Activity
Tian Liu,Zhenkun Qin,Zhiyue Yang,Xiaoling Feng
DOI: https://doi.org/10.2147/ijgm.s446723
IF: 2.145
2024-02-28
International Journal of General Medicine
Abstract:Tian Liu, Zhenkun Qin, Zhiyue Yang, Xiaoling Feng Division of General Practice, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, People's Republic of China Correspondence: Xiaoling Feng, Division of General Practice, The Fifth Affiliated Hospital of Xinjiang Medical University, No. 118, Henan West Road, Urumqi, Xinjiang Uygur Autonomous Region, 830011, People's Republic of China, Email Background: Numerous non-invasive serologic tests are available to diagnose and monitor ulcerative colitis (UC), but their accuracy levels are limited. Thus, there is a pressing need for a serologic biomarker with higher precision for clinical practice. This study aims to evaluate the predictive capacity of monocyte/HDL ratio (MHR) and neutrophil/lymphocyte ratio (NLR) for UC disease activity. Patients and Methods: We conducted a retrospective analysis of 81 UC patients and 77 age- and sex-matched healthy controls. UC patients were categorized into active and inactive groups based on the Mayo score. The Mayo endoscopic subscore classified them into mild-to-moderate and severe UC groups. Results: The optimal cut-off values for diagnosing UC were 0.34 for MHR (85.7% sensitivity, 76.0% specificity, 88.9% positive predictive value, 70.4% negative predictive value) and 2.49 for NLR (66.1% sensitivity, 88.0% specificity, 92.5% positive predictive value, 53.7% negative predictive value). The optimal MHR and NLR cut-off values to differentiate between mild-to-moderate UC and severe UC were 0.38 (92.9% sensitivity, 56.6% specificity, 53.1% positive predictive value, 93.7% negative predictive value) and 3.46 (71.4% sensitivity, 88.7% specificity, 76.9% positive predictive value, 85.5% negative predictive value), respectively. Conclusion: NLR and MHR are simple yet effective biological predictors of disease activity in UC patients. Keywords: ulcerative colitis, monocyte/HDL ratio, neutrophil/lymphocyte ratio, disease activity Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology, characterized by inflammation extending from the rectum to the colon's mucosal and submucosal layers. 1 Evaluating intestinal inflammation is critical for UC disease management. 2 While endoscopy and pathologic biopsy are standard methods for assessing UC clinical and endoscopic disease activity, they are invasive and associated with potential risks. Non-invasive tests, such as white blood cell (WBC) count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and fecal calprotectin (FC), are commonly used but have limited accuracy. 3–5 To meet clinical demands, various inflammatory markers derived from serologic indices have been developed. Monocytes and neutrophils are crucial components of innate immunity and play a significant role in the development of UC. Similarly, lymphocytes are involved in the pathology of UC. Some UC patients exhibit an elevation in circulating neutrophils and monocytes along with a reduction in lymphocyte levels. 6 Additionally, HDL cholesterol is involved in anti-oxidant and anti-inflammatory processes, and lower HDL cholesterol levels are associated with UC disease activity. 7 Torun et al 8 observed that elevated neutrophil/lymphocyte ratio (NLR) can predict disease activity in UC patients. The monocyte/HDL ratio (MHR) combines pro- and anti-inflammatory processes and may be useful in determining disease activity in UC patients. It is worth noting that NLR and MHR are cost-effective, noninvasive biomarkers of inflammation calculated from complete blood count and high-density lipoprotein levels. Previous studies have shown their utility in assessing systemic inflammation in various conditions, including infections, neoplasms, and cardiovascular disease. 9–12 This study evaluated the value of MHR and NLR as biomarkers of UC disease activity. This single-center retrospective cross-sectional study included a total of consecutive patients with UC and age-sex-matched healthy controls admitted to the Fifth Affiliated Hospital of Xinjiang Medical University between January 2019 and December 2022. The healthy controls were recruited from subjects who underwent colonoscopy at our hospital and had normal results. All patients underwent a complete colonoscopy and laboratory testing. Medical history data, including sex, age, disease duration, disease extension, surgical history, personal history, drug history, colonoscopy, and laboratory findings, were extracted from the hospital's electronic medical records. Exclusion criteria include serious cardiovascular diseases, infectious diseases, malignant neoplasms, and other major systemic diseases. Clinical activity in UC patients is assessed using the Mayo score, which includes stoo -Abstract Truncated-
medicine, general & internal